Cerebrospinal fluid catecholamines in Alzheimer’s disease patients with and without biological disease

Cerebrospinal fluid catecholamines in Alzheimer’s disease patients with and without biological disease

Noradrenergic and dopaminergic neurons are involved in cognitive functions, relate to behavioral and psychological symptoms in dementia and are affected in Alzheimer’s disease (AD). Amyloid plaques (A), neurofibrillary tangles (T) and neurodegeneration (N) hallmarks the AD neuropathology. Today, the...

Full description

Bibliographic Details
Main Authors:	Blennow, K. (Author), Bollerslev, J. (Author), Eldholm, R.S (Author), Godang, K. (Author), Halaas, N.B (Author), Henjum, K. (Author), Knapskog, A.B (Author), Saltvedt, I. (Author), Watne, L.O (Author), Zetterberg, H. (Author)
Format:	Article
Language:	English
Published:	Springer Nature 2022
Subjects:	Alzheimer disease Alzheimer Disease amyloid beta protein Amyloid beta-Peptides biological marker Biomarkers catecholamine Catecholamines cerebrospinal fluid cognitive defect Cognitive Dysfunction complication dopamine Dopamine epinephrine Epinephrine human Humans neurogranin Neurogranin noradrenalin Norepinephrine peptide fragment Peptide Fragments tau protein tau Proteins
Online Access:	View Fulltext in Publisher

Similar Items

Catecholamines in Alzheimer's Disease: A Systematic Review and Meta-Analysis
by: Xiongfeng Pan, et al.
Published: (2020-09-01)

Interaction studies on catecholamines to cellular receptors using in silico approach
by: S. Kalaivannan, et al.
Published: (2017-06-01)

The past and the future of Alzheimer’s disease CSF biomarkers – a journey towards validated biochemical tests covering the whole spectra of molecular events
by: Kaj eBlennow
Published: (2015-09-01)

Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg
by: Pawel Obrocki, et al.
Published: (2020-02-01)

Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines
by: Heidi N. Boyda, et al.
Published: (2020-12-01)

Review Paper: Tau Pathology of Alzheimer Disease: Possible Role of Sleep Deprivation
by: Nahid Ahmadian, et al.
Published: (2018-09-01)

Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy
by: Kevin A. Clayton, et al.
Published: (2017-12-01)

Molecular biomarkers of Alzheimer's disease: progress and prospects
by: Tammaryn Lashley, et al.
Published: (2018-05-01)

Systematic Morphometry of Catecholamine Nuclei in the Brainstem
by: Domenico Bucci, et al.
Published: (2017-11-01)

Neurobiological pathways to Alzheimer's disease: Amyloid-beta, TAU protein or both?
by: Vanessa de Jesus R. de Paula, et al.

Fluid biomarkers in clinical trials of Alzheimer’s disease therapeutics
by: Aaron eRitter, et al.
Published: (2015-08-01)

Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer’s disease
by: Madhurima Chatterjee, et al.
Published: (2018-06-01)

Peptide Interference with APP and Tau Association: Relevance to Alzheimer’s Disease Amelioration
by: Ruth Maron, et al.
Published: (2020-05-01)

Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke
by: Ann De Vos, et al.
Published: (2017-08-01)

Advantages and Pitfalls in Fluid Biomarkers for Diagnosis of Alzheimer’s Disease
by: Syed Haris Omar, et al.
Published: (2020-07-01)

Plant Neurobiology, a Fascinating Perspective in the Field of Research on Plant Secondary Metabolites
by: Marcello Iriti
Published: (2013-05-01)

Alzheimer’s Disease—A Panorama Glimpse
by: Li Na Zhao, et al.
Published: (2014-07-01)

Catecholamines in Post-traumatic Stress Disorder: A Systematic Review and Meta-Analysis
by: Xiongfeng Pan, et al.
Published: (2018-12-01)

Microneedle-based nanoporous gold electrochemical sensor for real-time catecholamine detection
by: Antiochia, R., et al.
Published: (2022)

Amyloid-beta in poststroke cognitive impairment
Published: (2015)

Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer’s dementia in mild cognitive impairment patients
by: Bali, D., et al.
Published: (2022)

Alzheimer’s disease as an inflammatory disease
by: Bolós Marta, et al.
Published: (2017-03-01)

The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease
by: Juanjuan Zhao, et al.
Published: (2017-07-01)

The role of autophagy in Alzheimer's disease and its potential for therapy
by: Min LIU, et al.
Published: (2014-05-01)

Aβ and tau structure‐based biomarkers for a blood‐ and CSF‐based two‐step recruitment strategy to identify patients with dementia due to Alzheimer's disease
by: Andreas Nabers, et al.
Published: (2019-12-01)

Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau
by: Hong-Qi Yang, et al.
Published: (2012-10-01)

Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals
by: Sylvain Lehmann, et al.
Published: (2020-10-01)

Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease
by: Mari Aksnes, et al.
Published: (2021-06-01)

Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1–42)/Aβ(1–40)
by: Hugo Vanderstichele, et al.
Published: (2017-06-01)

Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer’s Disease
by: Mari Aksnes, et al.
Published: (2021-01-01)

Membranes biomimétiques pour la caractérisation de nouveaux agents thérapeutiques : application à la maladie d'Alzheimer
by: Smeralda, Willy
Published: (2019)

Tau Depletion in APP Transgenic Mice Attenuates Task-Related Hyperactivation of the Hippocampus and Differentially Influences Locomotor Activity and Spatial Memory
by: Misato Yoshikawa, et al.
Published: (2018-03-01)

Effects of the Pentapeptide P33 on Memory and Synaptic Plasticity in APP/PS1 Transgenic Mice: A Novel Mechanism Presenting the Protein Fe65 as a Target
by: Titanilla Szögi, et al.
Published: (2019-06-01)

Role of the N-Terminal Hydrophilic Region of Amyloid Beta Peptide in Amyloidogenesis, Membrane Interaction and Toxicity Associated with Alzheimer’s Disease

Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder
by: Marcella Catania, et al.
Published: (2019-11-01)

Cerebrospinal fluid amyloid beta and tau protein: Biomarkers for Alzheimer's disease
by: Mandić Gorana, et al.
Published: (2008-01-01)

Peptides as Potential Therapeutics for Alzheimer’s Disease
by: Samo Ribarič
Published: (2018-01-01)

Assessment of Amyloid Forming Tendency of Peptide Sequences from Amyloid Beta and Tau Proteins Using Force-Field, Semi-Empirical, and Density Functional Theory Calculations
by: Charuvaka Muvva, et al.
Published: (2021-03-01)

Etude de la dynamique de tau dans le compartiment synaptique dans un contexte physiologique et pathologique exemple de la maladie d'Alzheimer
by: Frandemiche, Marie-Lise
Published: (2013)

Implications of GABAergic neurotransmission in Alzheimer’s disease
by: Yanfang eLi, et al.
Published: (2016-02-01)